Use of recombinant activated factor VII (Novoseven) in trauma and surgery: Analysis of outcomes reported to an international registry
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11140%2F06%3A00000589" target="_blank" >RIV/00216208:11140/06:00000589 - isvavai.cz</a>
Result on the web
—
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Use of recombinant activated factor VII (Novoseven) in trauma and surgery: Analysis of outcomes reported to an international registry
Original language description
Blood loss was markedly reduced in 93.0% patients, and transfusion requirements decreased after recombinant activated factor VII administration. Mortality rate in trauma patients who had massive hemorrhage was significantly reduced.
Czech name
Užití rekombinantního aktivovaného faktoru VII (Novoseven) u traumat a vchirurgii: Analýza výsledků léčby uváděná do mezinárodního registru
Czech description
Užití rekombinantního aktivovaného faktoru VII (Novoseven) u traumat a vchirurgii: Analýza výsledků léčby uváděná do mezinárodního registru.
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FP - Other medical fields
OECD FORD branch
—
Result continuities
Project
—
Continuities
V - Vyzkumna aktivita podporovana z jinych verejnych zdroju
Others
Publication year
2006
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Journal of Intensive Care Medicine
ISSN
0885-0666
e-ISSN
—
Volume of the periodical
21
Issue of the periodical within the volume
1
Country of publishing house
US - UNITED STATES
Number of pages
13
Pages from-to
27-39
UT code for WoS article
—
EID of the result in the Scopus database
—